Overview

Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections

Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if EL219 is safe and effective compared to the standard of care for early treatment of suspected invasive mould infection.
Phase:
PHASE2
Details
Lead Sponsor:
Elion Therapeutics, Inc.